Casale Donn bought SPRY
October 1, 2026 · Form 4 insider transaction
Casale Donn bought 1,036,923 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,036,923
Price
$0.00
Total value
N/A
InsiderCasale Donn
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 1, 2026
Filing dateOctober 5, 2026
Shares owned after1,036,923
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the option vest on July 7, 2027, and the remaining shares will vest monthly thereafter over three years.